Actinic Keratosis
📧 Sign up to get email alerts when something new happens for Actinic Keratosis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-05-25FDA Approved: AMELUZ — Supplemental Application (Biofrontera Inc.)
The FDA approved a supplemental application for AMELUZ (AMINOLEVULINIC ACID HYDROCHLORIDE) from Biofrontera Inc.
-
CLINICAL_TRIALS trial_result · 2021-05-25Clinical Trial Update: Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic Keratosis [Phase 1, Phase 2]
This clinical trial update reports safety and efficacy data for Ingenol Mebutate applied once daily for 2 or 3 consecutive days in subjects …
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: Activity & Safety Study of KX2-391 Ointment in Participants With Actinic Keratosis on the Face or Scalp [Phase 2]
Phase 2 trial update for KX2-391 ointment in actinic keratosis on face/scalp; study completed with posted results in 2021.
-
CLINICAL_TRIALS trial_result · 2021-03-10Clinical Trial Update: A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on AK on Face or Scalp [Phase 3]
Phase 3 trial completed evaluating the efficacy and safety of KX2-391 1% ointment for actinic keratoses on face or scalp.
-
CLINICAL_TRIALS trial_result · 2021-03-10Clinical Trial Update: A Multi-Center Study to Evaluate the Efficacy and Safety of KX2-391 Ointment 1% on Actinic Keratosis on Face or Scalp (AK004) [Phase 3]
Phase 3 trial assessing the efficacy and safety of KX2-391 1% ointment for actinic keratosis on face or scalp completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-09Clinical Trial Update: Menthol for PDT Pain Relief [Phase 4]
Phase 4 clinical trial update evaluating menthol for pain relief during photodynamic therapy in actinic keratosis has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Microwave Therapy for Treatment of Precancerous Actinic Keratoses [NA]
Completed clinical trial examining microwave therapy for precancerous actinic keratoses with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-02-18Clinical Trial Update: Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp [Phase 3]
Phase 3 clinical trial comparing Metvix PDT to vehicle PDT with Aktilite CL128 lamp for actinic keratosis on face and scalp completed.
-
FDA approval · 2021-01-26FDA Approved: IMIQUIMOD — Original Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved Sun Pharmaceutical's Imiquimod as an Original Application (generic) product. It covers actinic keratosis, superficial basal…
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: To Compare Safety and Efficacy of Perrigo's Drug Product Compared to an FDA Approved Drug Product in the Treatment of Actinic Keratosis [Phase 3]
Phase 3 trial comparing Perrigo's drug product to an FDA-approved product for actinic keratosis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: To Compare Safety and Efficacy of Perrigo's Drug Compared to an FDA Approved Drug in the Treatment of Actinic Keratosis [Phase 3]
Phase 3 trial comparing Perrigo's drug to an FDA-approved therapy for actinic keratosis has completed with posted results.
-
FDA approval · 2020-12-14FDA Approved: KLISYRI — Original Application (Almirall, LLC)
The FDA approved KLISYRI (tirbanibulin) 1% topical cream under its original application (NDA213189) from Almirall. It is indicated for actin…
-
CLINICAL_TRIALS trial_result · 2020-12-10Clinical Trial Update: Phase 3b Study of Metvix NDL-PDT Versus Metvix c-PDT in Subjects With Actinic Keratoses [Phase 3]
Phase 3b trial comparing Metvix NDL-PDT to Metvix c-PDT in actinic keratoses has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-11-09Clinical Trial Update: Daylight-PDT With MAL for AK and Photodamaged Skin [Phase 4]
Phase 4 clinical trial update for daylight-prefred PDT with MAL in actinic keratoses and photodamaged skin; study completed.
-
CLINICAL_TRIALS trial_result · 2020-10-30Clinical Trial Update: Study Comparing Imiquimod Cream, 3.75% to Zyclara® (Imiquimod) Cream, 3.75% in the Treatment of Actinic Keratosis [Phase 3]
A Phase 3 trial comparing Imiquimod 3.75% cream with Zyclara 3.75% cream for actinic keratosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-10-20Clinical Trial Update: Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream [Phase 2]
Phase 2 trial exploring genomic markers before and after treatment of actinic keratosis with imiquimod 3.75% cream.
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis [Phase 3]
Phase 3 bioequivalence trial comparing generic imiquimod 5% cream to Aldara 5% in actinic keratosis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Perimenstrual Acne With Clindamycin Phosphate and Benzoyl Peroxide [Phase 2]
Phase 2 trial update for perimenstrual acne using clindamycin phosphate and benzoyl peroxide; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-08-04Clinical Trial Update: Potential Impact of Patient Vitamin D Status in AK Response to MAL-PDT [NA]
A completed clinical trial from University of Sao Paulo evaluating how patient vitamin D status may influence actinic keratosis response to …
-
EMA withdrawal · 2020-07-31EMA Withdrawn: Picato (Ingenol mebutate) — LEO Laboratories Ltd.
EMA has withdrawn Picato (ingenol mebutate) from the market in Europe.
-
CLINICAL_TRIALS trial_result · 2020-07-29Clinical Trial Update: Risk of Squamous Cell Carcinoma on Skin Areas Treated With Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5% [Phase 4]
Phase 4 trial update on the risk of squamous cell carcinoma at skin sites treated with Ingenol Mebutate Gel 0.015% and Imiquimod Cream 5% in…
-
CLINICAL_TRIALS trial_result · 2020-07-20Clinical Trial Update: A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis [Phase 3]
Phase 3 trial comparing Diclofenac Sodium Gel 3% to Solaraze 3% in actinic keratosis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-05-12Clinical Trial Update: A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis [Phase 3]
Phase 3 trial comparing generic Ingenol Mebutate Gel 0.05% to Picato Gel 0.05% in actinic keratosis completed with results posted.
-
EMA safety_alert · 2020-04-30Risks of Picato for actinic keratosis outweigh benefits
The EMA states that the risks of Picato (ingenol mebate) for actinic keratosis outweigh the benefits and recommends restricting or withdrawi…
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream [Phase 3]
Phase 3 bioequivalence study comparing Sol-Gel Technologies' 5-FU cream with Efudex 5-FU cream for actinic keratosis has completed.